Uncategorized
FDA, Moderna appear aligned on mRNA flu shot heading into adcomm
The Vaccines and Related Biological Products Advisory Committee will meet June 18 to discuss Moderna’s seasonal flu vaccine mRNA-1010 after the FDA initially refused to accept the application in February.